Markets

Argenx (ARGX) reported Q3 2025 global product net sales of $1.13B and total operating income of $1.15B. Operating profit reached $346M, with $4.3B in cash and financial assets. The company reaffirmed its ~$2.5B combined R&D and SG&A guidance and plans to file an sBLA for seronegative gMG by year-end 2025, with ADAPT-OCULUS results expected in 1H26. Five registrational readouts are anticipated in 2026. A FUJIFILM manufacturing partnership expanded with a new North Carolina site.

MarketWise (MKTW) received an unsolicited proposal from Monument & Cathedral Holdings to acquire outstanding shares for $17.25 per share, contingent on terminating MarketWise’s tax receivable agreement (TRA). The Board is reviewing the proposal, but cautioned it may not lead to a transaction. Details are in Exhibit 99.2 of MarketWise’s Form 8-K filed on October 30, 2025. The TRA contingency adds complexity, potentially affecting deal value. Investors should watch for updates on the TRA’s status and Board’s assessment before making any investment decisions.

TeraWulf (WULF) priced a $900M private offering of 0.00% Convertible Senior Notes due 2032, potentially reaching $999.7M. Net proceeds will fund a data center campus in Abernathy, Texas, and general corporate expenditures. The initial conversion rate is 50.1567 shares per $1,000, implying a ~$19.94 conversion price. The notes, maturing May 1, 2032, include a 37.5% conversion premium and an option for initial purchasers to acquire an additional $125M.

National Healthcare Properties (NHPAP) will announce its Q3 2025 financial results on November 5, 2025, after market close. A live webcast to discuss the results will be held on November 6, 2025, at 1:00 p.m. ET. No pre-registration is required, and a replay will be available on the company’s website. Analysts will focus on occupancy rates in senior housing and capital allocation strategies. Investors should note the release and webcast timings to stay informed.

On October 29, 2025, Pegasus Resources (TSXV:PEGA; OTCID:SLTFF; FSE:OQS2) announced the immediate resignation of Noah Komavli from its Board of Directors, reducing the board to three members. The company acknowledged Komavli’s contributions. This change may lead to increased agility but raises questions about strategic shifts and the Jupiter Uranium Project’s future. Investors are watching for a potential replacement and further strategic direction.

Liberty Latin America is partnering with Starlink Direct to Cell to improve connectivity for FLOW Jamaica customers following Hurricane Melissa. This collaboration uses Starlink’s satellite network to provide critical data, SMS, and text communication when terrestrial infrastructure is compromised. By integrating satellite solutions, Liberty Latin America aims to maintain communication during emergencies, leveraging approved spectrum for seamless connectivity to mobile subscribers. This partnership signifies a broader trend of telecom providers utilizing satellite-based solutions for enhanced network resilience and coverage.

On October 29, 2025, SMX (NASDAQ:SMX) and trueGold unveiled a molecular-marking system for gold, creating a verifiable chain of custody. This tamper-proof signature, embedded at the source, addresses demand for transparency and ethical sourcing, using a proprietary marker, reader, and blockchain registry for a digital passport. The system offers origin, processing, and environmental impact insights. Intertek validation confirms safety, and partnerships with Ava Global and Fingo enhance logistics and access control. The technology aims to improve traceability, ESG substantiation and circular economy.

Liberty Global announced that Chairman John C. Malone will transition to Chairman Emeritus on January 1, 2026. Current CEO Mike Fries will succeed him as Chairman, maintaining his CEO role. Malone will remain a significant shareholder and provide strategic counsel. Fries has served as CEO since 2005 and will continue to guide the company, building upon Liberty Global’s focus on converged services, gigabit broadband, and shareholder value. The Board will consist of ten directors, with nine being independent. Liberty Global focuses on connectivity and investment to deliver long-term shareholder value.

Trailblazer Acquisition Corp (BLZRU) will allow separate trading of its Class A shares (BLZR) and warrants (BLZRW) starting October 31, 2025. Unit holders can elect to split their units; intact units will continue trading as BLZRU. No fractional warrants will be issued. The split aims to unlock value and attract diverse investors, but could fragment liquidity. This isn’t an offer to buy or sell securities where unlawful.

Purple Biotech (PPBT) has achieved a manufacturing milestone for IM1240, a CAPTN-3 tri-specific antibody targeting 5T4, CD3, and NKG2A. The company reports a commercially viable yield and high-purity process, validating the CAPTN-3 platform’s scalability. IM1240 incorporates a cleavable cap to limit systemic CD3 activation and extend half-life, concentrating activity in the tumor microenvironment. An Investigational New Drug (IND) submission is planned for 2026, advancing IM1240 towards first-in-human trials.